Table 1.
Demographic and clinicopathologic characteristics of HPV-positive patients from both UM and TCGA cohort.
| Parameter | HPV(+) UM tumors | HPV(+)TCGA tumors | sum_all_HPV | HPV-16 UM tumors | HPV-16 TCGA tumors | sum_HPV-16 | UM vs TCGA Fisher’s Exact Test p value |
|---|---|---|---|---|---|---|---|
| 18 | 66 | 84 | 14 | 55 | 69 | ||
| Age at diagnosis | Age at diagnosis | ||||||
| Median (std) | 58.5 (7.3) | 57 (9.2) | 58 (7.7) | 57 (9.7) | 0.297 | ||
| Gender | Gender | ||||||
| Male | 17 | 60 | 77 | 13 | 49 | 62 | 1.000 |
| Female | 1 | 6 | 7 | 1 | 6 | 7 | |
| HPV type | HPV type | ||||||
| HPV16 | 14 | 55 | 69 | 14 | 55 | 69 | 0.729 |
| HPV18 | 1 | 0 | 1 | ||||
| HPV33 | 1 | 8 | 9 | ||||
| HPV35 | 2 | 3 | 5 | ||||
| Anatomical Site | Anatomical Site | ||||||
| Oropharynx | 17 | 47 | 64 | 13 | 40 | 53 | 0.059 |
| Oral Cavity | 1 | 16 | 17 | 1 | 12 | 13 | |
| Larynx | 0 | 1 | 1 | 0 | 1 | 1 | |
| Hypopharynx | 0 | 2 | 2 | 0 | 2 | 2 | |
| Tumor Stage | Tumor Stage | ||||||
| I | 0 | 2 | 2 | 0 | 1 | 1 | 0.753 |
| II | 1 | 10 | 11 | 1 | 9 | 10 | |
| III | 2 | 7 | 9 | 2 | 6 | 8 | |
| IV | 15 | 47 | 62 | 11 | 39 | 50 | |
| T stage | T stage | ||||||
| T1 | 1 | 8 | 1 | 5 | 6 | 0.715 | |
| T2 | 7 | 31 | 6 | 28 | 34 | ||
| T3 | 3 | 10 | 13 | 2 | 9 | 11 | |
| T4 | 7 | 16 | 23 | 5 | 12 | 17 | |
| N stage | N stage | ||||||
| N0 | 1 | 18 | 19 | 1 | 15 | 16 | 0.156 |
| N1 | 2 | 6 | 8 | 2 | 4 | 6 | |
| N2 | 11 | 39 | 50 | 10 | 33 | 43 | |
| N3 | 4 | 2 | 6 | 1 | 2 | 3 | |
| Smoking Status | |||||||
| Current | 3 | 13 | 16 | 3 | 10 | 13 | Smoking Status |
| Former | 11 | 30 | 41 | 7 | 26 | 33 | 0.635 |
| Never | 4 | 22 | 26 | 4 | 19 | 23 | |